Multiple endocrine neoplasia type 2 (MEN 2) is a hereditary cancer syndrome associated primarily with tumors of the adrenal gland, thyroid and parathyroid. It is further classified into MEN2A and MEN2B. This activity describes the evaluation and management of multiple endocrine neoplasia type 2 and reviews the role of the interprofessional team in improving care for patients with this condition.

**Objectives:**
- Identify the germline RET mutations in the etiology of multiple endocrine neoplasia type 2.
- Explain the epidemiology of multiple endocrine neoplasia type 2.
- Review the use of total prophylactic thyroidectomy and lymph node dissection in the management of multiple endocrine neoplasia type 2.
- Summarize the importance of collaboration and communication among the interprofessional team to provide counseling and genetic testing to first degree relatives of those affected with multiple endocrine neoplasia type 2.